Back to Urology
Urologyv2011Evidence-Based

CAPRA-S

Cancer of the Prostate Risk Assessment post-surgical score.

Clinical Input Parameters

ng/mL
Range: 0.1 — 200 ng/mL
Clinical Assessment
Awaiting Parameters
capra s
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CAPRA-S is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

PSA 0-3 + Gleason 0-3 + margin 0/2 + ECE 0/1 + SVI 0/2 + LNI 0/1; total 0-12.

Evidence & Literature Citations

  1. Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score. Eur Urol. 2011;60(2):327-337.

Score Interpretation Ranges

High risk6 – pts

High risk of recurrence

Intermediate risk3 – pts

Intermediate risk

Low risk0 – pts

Low risk of recurrence

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.